Studies on heterocyclic compounds. II. Syntheses and pharmacologic activities of 1,3,5 triazine derivatives (Japanese)

DOI: 10.1248/yakushi1947.95.5_512

Source and publish data:

Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan p. 512 - 520 (1975)

Update date:2022-08-04

Topics:

Authors:

Tsujikawa

Tsukamura

Takei Takei

Sirakawa

Chiba Chiba

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/yakushi1947.95.5_512

Full text of DOI:10.1248/yakushi1947.95.5_512

NII-Electronic Library Service

Products guided by the article

Product name:4-methoxy-6-[2-(4-phenyl-piperazin-1-yl)-ethyl]-[1,3,5]triazin-2-ylamine

Cas No:5631-11-8

R&D Labs maybe for 5631-11-8

Beijing Tianjia Chemical Science & Technology Co.,Ltd

Contact:86-0550-2392698

Address:No.388, Shiliang Road (East),
Sichuan WeiKeqi Biological Technology Co., Ltd.

website:https://www.weikeqi-biotech.com/en

Contact:86-028-81700200

Address:sichuan Chengdu Qingjiang Zhonglu 63号
xuri chemicals co., ltd

Contact:86-516-66656369

Address:The west road of Huaihai, Xuzhou, China
Shenzhen Sunrising Industry Co., ltd.

Contact:+86 755 86571158 / 86571159 / 86571160

Address:2108 ZHENYE INT. BUSINESS CENTER,NO.3101-90 QIANHAI RD, NANSHAN,SHENZHEN, CHINA
Anhui New Star Pharmaceutical Development Co., Ltd

Contact:013956922763

Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China

Relevant to this article

Doi:10.1039/jr9530000951
(1953)
Discovery of 5-substituted-N-arylpyridazinones as inhibitors of p38 MAP kinase

Doi:10.1016/j.bmcl.2010.03.088
(2010)
Preparation and properties of sterically protected diphosphene and fluorenylidenephosphine bearing the 2,6-di-tert-butyl-4-methoxyphenyl group

Doi:10.1246/cl.2003.430
(2003)
Alkyl substituent effects on reductive elimination reactions in zirconocene alkyl hydride complexes. Manipulation of the alkyl steric environment allows the synthesis of a zirconocene dinitrogen complex

Doi:10.1021/om0302239
(2003)
Doi:10.1021/ja00847a026
(1975)
Novel and potent human and rat β₃-adrenergic receptor agonists containing substituted 3-indolylalkylamines

Doi:10.1016/S0960-894X(03)00073-8
(2003)

Article Doi